1
|
Li J, Gao K, Cai S, Liu Y, Wang Y, Huang S, Zha J, Hu W, Yu S, Yang Z, Xie H, Yan H, Wang J, Wu Y, Jiang Y. Germline de novo variants in CSNK2B in Chinese patients with epilepsy. Sci Rep 2019; 9:17909. [PMID: 31784560 PMCID: PMC6884442 DOI: 10.1038/s41598-019-53484-9] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2019] [Accepted: 10/16/2019] [Indexed: 01/16/2023] Open
Abstract
CSNK2B, which encodes the beta subunit of casein kinase II (CK2), plays an important role in neuron morphology and synaptic transmission. Variants in CSNK2B associated with epilepsy and/or intellectual disability (ID)/developmental delay (DD) have been reported in five cases only. Among the 816 probands suspected hereditary epilepsy whose initial report of trio-based whole exome sequencing (WES) were negative, 10 de novo pathogenic or likely pathogenic variants of CSNK2B in nine probands were identified after reanalysis of their raw Trio-WES data. Six of the nine epileptic patients had ID/DD. The age of seizure onset of these nine patients with CSNK2B variants ranged from 2–12 months. Eight patients had age of seizure onset of less than 6 months. The epilepsy of most probands (8/9) was generalized tonic-clonic seizure and clustered (6/9). Most patients had normal electroencephalogram (5/9) and brain magnetic resonance image (7/9) results. Most patients (7/9) had easy-to-control seizures. Levetiracetam was the most commonly used drug in seizure-free patients (5/7). The variants detected in five patients (5/9, 55.6%) were located in the zinc-binding domain. In summary, our research provided evidence that variants in CSNK2B are associated with epilepsy with or without ID/DD. CSNK2B-related epilepsy is relatively easy to be controlled. The zinc-binding domain appears to be the hotspot region for mutation.
Collapse
Affiliation(s)
- Jinliang Li
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
| | - Kai Gao
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
| | - Shuying Cai
- Department of Pediatric Neurology Rehabilitation, Maternal and Child Health Care of Xiamen, Xiamen, Fujian, 361003, China
| | - Yin Liu
- Department of Pediatric Neurology, Tangshan Maternal and Child Health Hospital, Tangshan, Hebei, 063000, China
| | - Yuzhen Wang
- Department of Pediatric Neurology, Tangshan Maternal and Child Health Hospital, Tangshan, Hebei, 063000, China
| | - Shaoping Huang
- Department of Pediatrics, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, 710004, China
| | - Jian Zha
- Department of Pediatric Neurology, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, 330006, China
| | - Wenjing Hu
- Second Department of Neurology, Hunan Province Children's Hospital, Changsha, Hunan, 410007, China
| | - Shujie Yu
- Department of Pediatric Neurology, Harbin Children's Hospital, Harbin, Heilongjiang, 150010, China
| | - Zhixian Yang
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
| | - Han Xie
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
| | - Huifang Yan
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
| | - Jingmin Wang
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
| | - Ye Wu
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
| | - Yuwu Jiang
- Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China.
| |
Collapse
|
2
|
Lyon KF, Cai X, Young RJ, Mamun AA, Rajasekaran S, Schiller MR. Minimotif Miner 4: a million peptide minimotifs and counting. Nucleic Acids Res 2019; 46:D465-D470. [PMID: 29140456 PMCID: PMC5753208 DOI: 10.1093/nar/gkx1085] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2017] [Accepted: 11/09/2017] [Indexed: 12/27/2022] Open
Abstract
Minimotif Miner (MnM) is a database and web system for analyzing short functional peptide motifs, termed minimotifs. We present an update to MnM growing the database from ∼300 000 to >1 000 000 minimotif consensus sequences and instances. This growth comes largely from updating data from existing databases and annotation of articles with high-throughput approaches analyzing different types of post-translational modifications. Another update is mapping human proteins and their minimotifs to know human variants from the dbSNP, build 150. Now MnM 4 can be used to generate mechanistic hypotheses about how human genetic variation affect minimotifs and outcomes. One example of the utility of the combined minimotif/SNP tool identifies a loss of function missense SNP in a ubiquitylation minimotif encoded in the excision repair cross-complementing 2 (ERCC2) nucleotide excision repair gene. This SNP reaches genome wide significance for many types of cancer and the variant identified with MnM 4 reveals a more detailed mechanistic hypothesis concerning the role of ERCC2 in cancer. Other updates to the web system include a new architecture with migration of the web system and database to Docker containers for better performance and management. Weblinks:minimotifminer.org and mnm.engr.uconn.edu
Collapse
Affiliation(s)
- Kenneth F Lyon
- Nevada Institute of Personalized Medicine and School of Life Sciences, University of Nevada, Las Vegas, 89154 4004 NV, USA
| | - Xingyu Cai
- Department of Computer Science and Engineering, University of Connecticut, Storrs, CT 06269 2155, USA
| | - Richard J Young
- Nevada Institute of Personalized Medicine and School of Life Sciences, University of Nevada, Las Vegas, 89154 4004 NV, USA
| | - Abdullah-Al Mamun
- Department of Computer Science and Engineering, University of Connecticut, Storrs, CT 06269 2155, USA
| | - Sanguthevar Rajasekaran
- Department of Computer Science and Engineering, University of Connecticut, Storrs, CT 06269 2155, USA
| | - Martin R Schiller
- Nevada Institute of Personalized Medicine and School of Life Sciences, University of Nevada, Las Vegas, 89154 4004 NV, USA
| |
Collapse
|
3
|
Abstract
All proteins end with a carboxyl terminus that has unique biophysical properties and is often disordered. Although there are examples of important C-termini functions, a more global role for the C-terminus is not yet established. In this review, we summarize research on C-termini, a unique region in proteins that cells exploit. Alternative splicing and proteolysis increase the diversity of proteins and peptides in cells with unique C-termini. The C-termini of proteins contain minimotifs, short peptides with an encoded function generally characterized as binding, posttranslational modifications, and trafficking. Many of these activities are specific to minimotifs on the C-terminus. Approximately 13% of C-termini in the human proteome have a known minimotif, and the majority, if not all of the remaining termini have conserved motifs inferring a function that remains to be discovered. C-termini, their predictions, and their functions are collated in the C-terminome, Proteus, and Terminus Oriented Protein Function INferred Database (TopFIND) database/web systems. Many C-termini are well conserved, and some have a known role in health and disease. We envision that this summary of C-termini will guide future investigation of their biochemical and physiological significance.
Collapse
Affiliation(s)
- Surbhi Sharma
- a Nevada Institute of Personalized Medicine and School of Life Sciences , University of Nevada , Las Vegas , NV , USA
| | - Martin R Schiller
- a Nevada Institute of Personalized Medicine and School of Life Sciences , University of Nevada , Las Vegas , NV , USA
| |
Collapse
|
4
|
Sharma S, Young RJ, Chen J, Chen X, Oh EC, Schiller MR. Minimotifs dysfunction is pervasive in neurodegenerative disorders. ALZHEIMER'S & DEMENTIA (NEW YORK, N. Y.) 2018; 4:414-432. [PMID: 30225339 PMCID: PMC6139474 DOI: 10.1016/j.trci.2018.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Minimotifs are modular contiguous peptide sequences in proteins that are important for posttranslational modifications, binding to other molecules, and trafficking to specific subcellular compartments. Some molecular functions of proteins in cellular pathways can be predicted from minimotif consensus sequences identified through experimentation. While a role for minimotifs in regulating signal transduction and gene regulation during disease pathogenesis (such as infectious diseases and cancer) is established, the therapeutic use of minimotif mimetic drugs is limited. In this review, we discuss a general theme identifying a pervasive role of minimotifs in the pathomechanism of neurodegenerative diseases. Beyond their longstanding history in the genetics of familial neurodegeneration, minimotifs are also major players in neurotoxic protein aggregation, aberrant protein trafficking, and epigenetic regulation. Generalizing the importance of minimotifs in neurodegenerative diseases offers a new perspective for the future study of neurodegenerative mechanisms and the investigation of new therapeutics.
Collapse
Affiliation(s)
- Surbhi Sharma
- Nevada Institute of Personalized Medicine, Las Vegas, NV, USA
- School of Life Sciences, Las Vegas, NV, USA
| | - Richard J. Young
- Nevada Institute of Personalized Medicine, Las Vegas, NV, USA
- School of Life Sciences, Las Vegas, NV, USA
| | - Jingchun Chen
- Nevada Institute of Personalized Medicine, Las Vegas, NV, USA
| | - Xiangning Chen
- Nevada Institute of Personalized Medicine, Las Vegas, NV, USA
- Department of Psychology, Las Vegas, NV, USA
| | - Edwin C. Oh
- Nevada Institute of Personalized Medicine, Las Vegas, NV, USA
- School of Medicine, Las Vegas, NV, USA
| | - Martin R. Schiller
- Nevada Institute of Personalized Medicine, Las Vegas, NV, USA
- School of Life Sciences, Las Vegas, NV, USA
- School of Medicine, Las Vegas, NV, USA
| |
Collapse
|
5
|
Abstract
Several theories for the origin of life have gained widespread acceptance, led by primordial soup, chemical evolution, metabolism first, and the RNA world. However, while new and existing theories often address a key step, there is less focus on a comprehensive abiogenic continuum leading to the last universal common ancestor. Herein, I present the "minimotif synthesis" hypothesis unifying select origin of life theories with new and revised steps. The hypothesis is based on first principles, on the concept of selection over long time scales, and on a stepwise progression toward complexity. The major steps are the thermodynamically-driven origination of extant molecular specificity emerging from primordial soup leading to the rise of peptide catalysts, and a cyclic feed-forward catalytic diversification of compound and peptides in the primordial soup. This is followed by degenerate, semi-partially conservative peptide replication to pass on catalytic knowledge to progeny protocells. At some point during this progression, the emergence of RNA and selection could drive the separation of catalytic and genetic functions, allowing peptides and proteins to permeate the catalytic space, and RNA to encode higher fidelity information transfer. Translation may have emerged from RNA template driven organization and successive ligation of activated amino acids as a predecessor to translation.
Collapse
Affiliation(s)
- Martin R Schiller
- Nevada Institute of Personalized Medicine and School of Life Sciences, University of Nevada, Las Vegas, Nevada, USA
| |
Collapse
|
6
|
Sharma S, Toledo O, Hedden M, Lyon KF, Brooks SB, David RP, Limtong J, Newsome JM, Novakovic N, Rajasekaran S, Thapar V, Williams SR, Schiller MR. The Functional Human C-Terminome. PLoS One 2016; 11:e0152731. [PMID: 27050421 PMCID: PMC4822787 DOI: 10.1371/journal.pone.0152731] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2015] [Accepted: 03/18/2016] [Indexed: 11/24/2022] Open
Abstract
All translated proteins end with a carboxylic acid commonly called the C-terminus. Many short functional sequences (minimotifs) are located on or immediately proximal to the C-terminus. However, information about the function of protein C-termini has not been consolidated into a single source. Here, we built a new "C-terminome" database and web system focused on human proteins. Approximately 3,600 C-termini in the human proteome have a minimotif with an established molecular function. To help evaluate the function of the remaining C-termini in the human proteome, we inferred minimotifs identified by experimentation in rodent cells, predicted minimotifs based upon consensus sequence matches, and predicted novel highly repetitive sequences in C-termini. Predictions can be ranked by enrichment scores or Gene Evolutionary Rate Profiling (GERP) scores, a measurement of evolutionary constraint. By searching for new anchored sequences on the last 10 amino acids of proteins in the human proteome with lengths between 3-10 residues and up to 5 degenerate positions in the consensus sequences, we have identified new consensus sequences that predict instances in the majority of human genes. All of this information is consolidated into a database that can be accessed through a C-terminome web system with search and browse functions for minimotifs and human proteins. A known consensus sequence-based predicted function is assigned to nearly half the proteins in the human proteome. Weblink: http://cterminome.bio-toolkit.com.
Collapse
Affiliation(s)
- Surbhi Sharma
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Oniel Toledo
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Michael Hedden
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Kenneth F. Lyon
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Steven B. Brooks
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Roxanne P. David
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Justin Limtong
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Jacklyn M. Newsome
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Nemanja Novakovic
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Sanguthevar Rajasekaran
- Department of Computer Science and Engineering, University of Connecticut, Storrs, Connecticut 06269–2155, United States of America
| | - Vishal Thapar
- Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts 02114, United States of America
| | - Sean R. Williams
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| | - Martin R. Schiller
- Nevada Institute of Personalized Medicine, and School of Life Sciences, University of Nevada, Las Vegas, Nevada, United States of America
| |
Collapse
|